公开(公告)号：US20190241566A1

公开(公告)日：2019-08-08

申请号：US16333296

申请日：2017-09-14

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Takaharu HIRAYAMA ,  Yasuhiro HIRATA ,  Yusuke TOMINARI ,  Naoki IWAMURA ,  Yusuke SASAKI ,  Moriteru ASANO ,  Terufumi TAKAGI ,  Masanori OKANIWA ,  Masato YOSHIDA ,  Takashi ICHIKAWA ,  Shinichi IMAMURA

IPC: C07D473/28 ,  C07D473/40 ,  C07D519/00 ,  C07D471/04 ,  C07D417/14 ,  C07D413/14 ,  C07D401/14 ,  C07D409/14 ,  C07D405/14 ,  C07D401/04 ,  A61P35/00

Abstract: Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula (I): wherein a group represented by is a group represented by the following formula (II) or the following formula (III): and other symbols are as described in the DESCRIPTION, or a salt thereof.